.
MergerLinks Header Logo

New Deal

New Deal

Cover Image Brad Bolzon
Brad BolzonVERSANT VENTURES

Brad Bolzon

Chairman at VERSANT VENTURES

Investor

Deal Bio

Total Deals4
Valued Deals4
Total Value£2,096M
Avg. Deal Size£524M
United States
Biotechnology
PrivateAcquisitionVenture CapitalPrivate Equity
Bluerock Therapeutics

target

Bluerock Therapeutics

Bayer

bidder

Bayer

£493m

21 dealmakers

Canada
Biotechnology
AcquisitionMinorityPrivate EquityPrivateVenture Capital
Chinook Therapeutics

target

Chinook Therapeutics

Ecor1 Capital

bidder

Ecor1 Capital

£80m

15 dealmakers

Switzerland
Biotechnology
Cross BorderAcquisitionPrivate EquityPrivateMinorityVenture Capital
VECTIVBIO

target

VECTIVBIO

Cormorant Asset Management

bidder

Cormorant Asset Management

£84m

35 dealmakers

United States
Biotechnology
PrivateMajorityAcquisitionPrivate EquityCross Border
Vividion Therapeutics

target

Vividion Therapeutics

Bayer

bidder

Bayer

£1,437m

47 dealmakers

Deal search form

Discover more deals

Boost your presence by claiming deals. Enhance your profile, highlighting your industry impact.

Claim more deals

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US